Curaleaf Laboratories can today announce a partnership agreement has been reached with Dalgety Ltd, to exclusively manufacture and distribute medical cannabis API produced from their state-of-the-art cultivation facility in the UK.
Dalgety, based in Derbyshire, are the first domestic cultivator of medical cannabis to hold EU-GMP licenses for the cultivation and supply of medical cannabis products. This exciting partnership showcases a full UK vertical supply chain in operation, from cultivation to distribution, while maintaining EU-GMP standards throughout the whole process.
As the largest MHRA-approved manufacturer and distributor of EU-GMP medical cannabis in the UK, Curaleaf Laboratories can now offer a line of fully UK-manufactured medicines. This is in addition to our already extensive range, delivering best-in-class products for specialist prescribers to consider for their patients.
Richard Hodgson, Managing Director of Curaleaf Laboratories: “We are delighted to announce our partnership with Dalgety. This provides a range of high quality EU-GMP products that have gone through a full UK supply chain, from cultivation to manufacture and distribution.
This partnership with a premium UK grower of EU-GMP medical cannabis shows our commitment towards widening choice with competitively priced products and a variety of strain profiles and dosage forms. Dalgety stood out as a producer so we are extremely excited for this partnership and look forward to seeing how our collaboration develops.”
James Leavesley, CEO of Dalgety Ltd: “This partnership with Curaleaf represents more than just operational alignment, it reflects a shared belief in what medical cannabis can and should be in the UK: safe, consistent, and rooted in integrity. As the sector matures, it’s vital we work with the right partners; those who not only meet high standards themselves, but who demand the same of everyone they work with. Together, we’re focused on building a resilient UK supply chain that puts patients first and safeguards the future of this medicine.”
If you are a pharmacist or healthcare professional looking for more information, please contact us at info@curaleaflaboratories.co.uk
If you are an interested patient, please visit Curaleaf Pharmacy
About Curaleaf Laboratories
Curaleaf Laboratories are the UK-leading experts in the manufacture and distribution of EU-GMP medical cannabis. With the largest state-of-the-art MHRA-approved medical cannabis manufacturing facility and a comprehensive quality management system, Curaleaf Laboratories is meeting the growing patient demand for a consistent range of medical cannabis manufactured to EU-GMP standards, with varying novel dosage forms and levels of cannabinoid content.
Part of the Curaleaf International group since 2019, Curaleaf Laboratories has evolved from a well-established specials medicines manufacturer with over a decade of expertise in unlicensed medicines. With that experience, Curaleaf Laboratories is widening access to clinics and pharmacies all across the UK, while leading the market as the most trusted manufacturer, distributor and partner.
About Dalgety
Dalgety is a UK-based medical cannabis cultivator focused on raising the standard of care through pharmaceutical-grade, EU GMP-certified cannabis medicines. As the first and only UK company licensed for the cultivation, manufacture, and supply of cannabis flower as an Active Pharmaceutical Ingredient (API), Dalgety is committed to building a trusted domestic supply chain rooted in scientific integrity, regulatory compliance, and patient-first values. With a highly controlled hydroponic environment and a commitment to consistency, Dalgety enables healthcare professionals to prescribe with confidence and patients to access reliable, high-quality treatment.